Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Cancer. 2021 Apr 7;127(13):2251–2261. doi: 10.1002/cncr.33483

TABLE 2.

Patterns of Initial Recurrence Based on Nodal Management and Receipt of Adjuvant Systemic Therapy

No. of Patients (%)
Nodal Management
Adjuvant Systemic Therapya
Site of Recurrence Dissection, N = 189 Surveillance, N = 965 Yes, N = 439 No, N = 712
No recurrence 148 (78) 786 (81) 358 (82) 573 (80)
Recurrence 41 (22) 179 (19) 81 (18) 139 (20)
 Local-regional onlyb 11 (6) 40 (4) 19 (4) 32 (5)
 SLN basin only 7 (4) 61 (6) 24 (5) 44 (6)
 Distant only 16 (8) 41 (4) 21 (5) 36 (5)
 Multiple sites 7 (4) 37 (4) 17 (4) 27 (4)
  Including nodal 4 (2) 35 (4) 14 (3) 24 (3)
  Not including nodal 3 (2) 2 (<1) 3 (1) 3 (1)

Abbreviation: SLN, sentinel lymph node.

a

Data regarding adjuvant therapy were not available for 3 participants.

b

Local-regional includes the primary site and in-transit disease.